GREENSBORO, N.C., Feb. 25, 2011 /PRNewswire/ -- Highlighting conflicts of interest and bias among members of a Food and Drug Administration (FDA) scientific advisory committee, Lorillard, Inc. (NYSE: LO ) today filed suit to stop FDA from receiving or relying on recommendations from the advisory committee, including recommendations regarding the use of menthol in cigarettes. In the complaint, Lorillard also asks the Court to enjoin the FDA from making available to the advisory committee any trade secret or confidential commercial documents submitted by the company to FDA until the advisory committee is lawfully constituted.